Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile

Academic Article

Publication Date:

2017

Short description:

Budesonide MMX Add-on to 5-Aminosalicylic Acid Therapy in Mild-to-Moderate Ulcerative Colitis: A Favourable Risk-Benefit Profile / Danese, S; Bonovas, S; Peyrin-Biroulet, L. - In: JOURNAL OF CROHN'S AND COLITIS. - ISSN 1873-9946. - 11:7(2017), pp. 767-768. [10.1093/ecco-jcc/jjx025]

Iris type:

1.1 Articolo in rivista

List of contributors:

Danese, S; Bonovas, S; Peyrin-Biroulet, L

Authors of the University:

DANESE SILVIO

Handle:

https://iris.unisr.it/handle/20.500.11768/119621

Published in:

JOURNAL OF CROHN'S AND COLITIS

Journal